JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation - Top-Institutions - MDSpire

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

  • By

  • Zhan-Qun Yang

  • Ning Ding

  • Meng-Zhu Zheng

  • Jian Wen

  • Yuan Xue

  • Li-Ting Zheng

  • Yi-Heng Yang

  • Cheng-He Shi

  • Hua Jiang

  • Jian Lin

  • Long Chen

  • May 11, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital / Johns Hopkins Medicine
    Johns Hopkins Hospital / Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Infectious Disease

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Infectious Disease

  • #3

    University of Rochester
    University of Rochester

    Rochester, New York

    Key Differentiators

    • Infectious Disease

  • #4

    Ohio State University College of Dentistry
    Ohio State University College of Dentistry

    Columbus, Ohio

    Key Differentiators

    • Infectious Disease

  • #5

    University Hospital Regensburg
    University Hospital Regensburg

    Regensburg, Germany

    Key Differentiators

    • Infectious Disease

Original Source(s)

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

  • by Zhan-Qun Yang, Ning Ding, Meng-Zhu Zheng, Jian Wen, Yuan Xue, Li-Ting Zheng, Yi-Heng Yang, Cheng-He Shi, Hua Jiang, Jian Lin, Long Chen

  • May 11, 2026

Related Content

Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germany

Complement activation in patients with post-acute sequelae after SARS-CoV-2 infection

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.